CATEGORIES

Policy and Practice

LATEST

TRENDING

EDITORS CHOICE

India’s Pivotal Regulatory Shift: A Possible Game-Changer in Expediting Medicines to Millions in Dire Need

“Go to India” May Be a Key Market for Pharma Company Growth and Global Public Health

“Investigational” Is Payer Code for “Coverage Denied”

Outside the pandemic, “investigational” remains payer code for denying reimbursement. In the case of treatment for chronic conditions, even FDA-approved digital-health and connected devices languish on waitlists for formulary inclusion.

Gabor Maté’s Bizarre Ideas on Connections Between Stress and Disease

Gabor Maté’s issues are with evidence, not the West and with public health, not medicine, but who takes him seriously? Lots of otherwise smart people seem to…or maybe not.

Patient Engagement Goes Back to the Future — How Far Have We Gone to Answer Consumers’ Needs?

24 Years After Publication - the 1st Book on Health Branding Offers Historic Perspective and a Crystal Ball on How Power Brands Save Lives